Skip to main content
Tech.euFundingExplorerBeta

Neurent Medical

the company behind NEUROMARK, a minimally invasive solution to treat chronic rhinitis

Total raised
€63M
€62,500,000
Funding rounds
1
Investors
7
distinct backers
Active since
2026-02
latest 2026-02

Funding by year

EUR raised per year · 2026 YTD

Signals

High confidence
Raise-next likelihood33
base rate 51% for Series C
  • Raised very recently
  • Low backer re-investment

Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds

Related news

Similar companies

same sector or country